A Study of BBI608 in Adult Patients With Advanced Malignancies

Clinical trial NCT01775423 · COMPLETED

Trial details

NCT number: NCT01775423
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer, Advanced Malignancies

Start date: 2009-03-01
Primary completion: 2015-08-06
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.